TendieTensor TendieTensor
You’re browsing as
Guest
Free Preview
Sign in/sign up to unlock all features.

News  ›  GlobeNewswire Inc.

Gene Therapies for Cancer Treatment Market Projects USD 238.77 Billion at 39.94% CAGR by 2034

GlobeNewswire Inc. Logo GlobeNewswire Inc. By Towards Healthcare
Gene Therapies for Cancer Treatment Market Projects USD 238.77 Billion at 39.94% CAGR by 2034

The global gene therapies for cancer treatment market is expected to grow from $8.28 billion in 2024 to $238.77 billion by 2034, with a 39.94% CAGR. North America currently dominates the market, with CAR-T cell therapy leading market share and significant innovations driving growth.

Insights
MSFT   positive

Part of top-performing Magnificent Seven stocks with strong market presence


LEGN   positive

Mentioned as a key player in an emerging and rapidly growing gene therapy market for cancer treatment